Exercise-plaque paradox

Endurance exercise is one of the most effective tools for protecting your heart. Yet cardiologists have noticed something unsettling in athletes who train for hours every day: they often have more arterial plaque than people who barely exercise at all. This is the exercise-plaque paradox, and the explanation that once seemed to resolve it is now under serious scientific pressure.

What the data show

Two broad findings sit in apparent conflict. High-volume endurance exercisers, roughly those training around 10 hours per week, accumulate significantly more arterial plaque than lightly active people training around 3 hours per week, with duration, not intensity, being the key driver. Verhoeven's analysis of the pre-2023 literature suggests this relationship is consistent across studies [1]. At the same time, exercise also reduces plaque through mechanisms including foam-cell mobilization, improved HDL-mediated cholesterol transport, and collateral vessel formation, with randomized controlled trial data showing reductions in necrotic plaque core [2].

For several years, the leading explanation was that these two findings could be reconciled by plaque type. Verhoeven's synthesis suggested athletes accumulate more total plaque, but that plaque is more densely calcified and therefore more stable, while the dangerous non-calcified and mixed plaques (the kind prone to rupturing and triggering heart attacks) are lower in athletes [1, 2]. Calcified plaque behaves more like scar tissue. Mixed plaque is the kind that kills people. If athletes had more of the former and less of the latter, the paradox dissolves into reassurance.

That resolution was always an analyst-level synthesis, not a primary finding. In 2023, a high-quality trial put it under direct pressure.

What Master@Heart found

The Master@Heart trial (De Bosscher et al., European Heart Journal, 2023) compared coronary plaque using CT angiography in lifelong endurance athletes, late-onset exercisers, and sedentary controls [3]. Lifelong athletes had significantly more non-calcified proximal plaques compared to sedentary controls, with an odds ratio of 2.80. Non-calcified proximal plaques are precisely the lesion type that the earlier synthesis said athletes would be protected against.

The numbers are worth reading carefully. In the lifelong athlete group, 11.8% of plaques were non-calcified, compared to 13.7% in sedentary controls, but athletes also had more mixed plaques (25.9% vs. 19.3%) and less calcified plaque (62.3% vs. 67.0%) [3]. On the key safety variable, the direction runs opposite to what the Verhoeven framing predicted.

A few caveats apply. The odds ratio of 2.80 is specific to proximal non-calcified segments, not total plaque composition. The trial enrolled European lifelong athletes and used CT angiography rather than the coronary artery calcium scoring that most earlier studies relied on, which makes direct comparisons difficult. A 2024 systematic review attempted to synthesize the conflicting literature, but had not yet been formally assessed for this analysis.

What remains uncertain

No study has yet tracked hard cardiovascular outcomes, actual heart attacks and strokes, in high-volume exercisers stratified by plaque type. The mortality data showing that calcified plaque is not dangerous comes from general populations, not from athletes with large plaque burdens acquired through decades of heavy training [1]. The long-term trajectory of those non-calcified proximal plaques found in Master@Heart athletes is unknown.

Measurement method also matters. Studies using self-reported exercise fail to show the plaque relationship at all; it only appears in studies using objective wearable devices [1]. This suggests a substantial portion of older research may have underestimated exercise volume and missed the association entirely. The available data also come predominantly from men, and applicability to women is unclear [1].

A separate concern: atrial fibrillation

Plaque is not the only cardiovascular risk associated with extreme training volumes. Expert analysis based on data from retired professional cyclists places AFib risk at roughly 7 times baseline in that population [4]. The proposed mechanism involves myocardial fiber stress leading to micro-islands of fibrosis, which in turn causes electrical instability in stiff, dilated chambers. This risk exists independently of plaque biology and warrants monitoring in anyone training at high volumes.

Where the evidence is contested

The central question, whether athlete plaque is predominantly the calcified, stable type rather than the vulnerable non-calcified variety, sits at the heart of the current dispute.

Verhoeven's analysis of earlier literature suggests high-volume athletes accumulate more calcified and less mixed plaque, making their higher plaque burden net-neutral or even favorable for cardiovascular risk [1, 2]. This framing was widely cited and informed a generation of reassuring messaging around endurance sport.

Master@Heart [3] directly contradicts this on its primary endpoint. In that trial, lifelong athletes carried more non-calcified proximal plaques than sedentary controls, with an OR of 2.80. The earlier analyst synthesis and the strongest available primary trial point in opposite directions on the variable that matters most: plaque stability.

Hard mortality outcomes for high-volume athletes stratified by plaque type have not been published. Until they are, stating that "athlete plaque is safer because it is calcified" goes beyond what the current evidence supports.

References

1. raw/physionic/physionic-exercise-duration-plaque*.txt
2. Physionic — Exercise-plaque paradox (athlete plaque type)
3. 36881712 (Master@Heart — contradicts the claim) · PubMed 36881712
4. Attia/O'Keefe — CVD risk from too much exercise (ep. 134)